- This event has passed.
December 8, 2017 @ 12:00 pm - 1:00 pm
“What is First Episode Psychosis?: An Overview and Best Practices”
Recently, there has been an increased interest in the development and delivery of early intervention services for a number of different mental illnesses. In the US, the federal government has increased support for the development of coordinated specialty care treatment teams to improve services for persons with first episode psychosis. NAVIGATE is the only evidenced-based program developed in the US to treat persons with first episode psychosis. In this webinar, practitioners will learn about the treatments included in the NAVIGATE model. Information also will be provided on how to recognize a person with first episode psychosis and some strategies to help engage people in mental health services for the first time.
Piper Meyer-Kalos, PhD, HCP-P, holds her doctoral degree in Clinical Rehabilitation Psychology from Indiana University – Purdue University, Indianapolis. She is the Executive Director of MNCAMH and was previously affiliated with the Department of Psychology at the University of North Carolina at Chapel Hill as a Research Associate Professor and as an Assistant Adjunct Professor in the UNC Department of Psychiatry.
Dr. Meyer-Kalos has specialized in psychiatric rehabilitation and treatment for first episode psychosis with interests in recovery, positive psychology, and psychosocial treatment for people with severe mental illness.
Since 2009, Dr. Meyer-Kalos has been part of the psychosocial development team of the Recovery After Initial Schizophrenia Episode (RAISE) project and has co-led the individual therapy component (Individual Resiliency Training) of that project. Dr. Meyer-Kalos’ current research projects include evaluation of the integrated treatment and training for mental health and substance abuse and chronic health problems in Minnesota. She was recently awarded an NIMH grant to develop a positive psychology/mindfulness based treatment to reduce stress reactivity in persons with first episode psychosis.